{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:21:13Z","timestamp":1787242873018,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is responsible for the most common sexually transmitted infection, particularly among sexually active individuals. Understanding the geographical distribution and epidemiology of the most prevalent HPV genotypes is essential for developing effective prevention strategies. Consequently, this study aimed to examine the distribution of HPV genotypes among HPV-positive women and men in Sari, the capital city of Mazandaran province in northern Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>HPV DNA was extracted (PZP Company, Molecular IVD, Iran) from genital and cervical samples of the study participants. Genotyping was conducted for 90 cases utilizing the High\u2009+\u2009Low Papilloma Strip test (Operon Company, Spain). Demographic data were statistically analyzed in correlation with the virological data (STATA version 17).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 67.7% (61 out of 90) of the cases tested positive for HPV, with 75% of those being classified as high-risk. The participant group consisted of 92% females (83) and 8% males\u00a0(7). The highest HPV prevalence, 75%\u00a0(36), was observed in females and males aged under 31, with the majority of positive cases belonging to high-risk genotypes. The most frequently identified genotypes were HPV-11 (23%), HPV-6 (21%), HPV-56 (18%), HPV-39 (16%), HPV-16, HPV-91, and HPV-66 each comprising (14%). HPV-56 was the most common high-risk genotype, accounting for 11 cases (18%), followed by HPV-39, which was present in 10 cases (16%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of HPV infection was particularly high among individuals under the age of 31 for both genders, with men exhibiting a 100% infection rate. These findings emphasize the urgent need for targeted education aimed at the younger population and the implementation of infection control measures. Specifically, widespread HPV vaccination targeting HPV-6, HPV-11, HPV-39, and HPV-56 should be prioritized for the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-024-02496-7","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:02:02Z","timestamp":1726808522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High prevalence of HPV-56 and HPV-39 in Sari, Iran: an analysis of genotype distribution"],"prefix":"10.1186","volume":"21","author":[{"given":"Arash","family":"Letafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Vasheghani","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mostafa Baradaran","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pourmoein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Salahi","family":"Ardekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh","family":"Ahoodashty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Bagher","family":"Hashemi-Soteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniseh","family":"Dadgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Behshood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Rezaee","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Parsania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"2","key":"2496_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/MMBR.68.2.362-372.2004","volume":"68","author":"MS Longworth","year":"2004","unstructured":"Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004;68(2):362\u201372.","journal-title":"Microbiol Mol Biol Rev"},{"key":"2496_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.virol.2014.12.028","volume":"476","author":"D Bzhalava","year":"2015","unstructured":"Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015;476:341\u20134.","journal-title":"Virology"},{"issue":"3","key":"2496_CR3","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3390\/ijms23031818","volume":"23","author":"DA Har\u0119\u017ca","year":"2022","unstructured":"Har\u0119\u017ca DA, Wilczy\u0144ski JR, Paradowska E. Human papillomaviruses as infectious agents in gynecological cancers. Oncogenic properties of viral proteins. Int J Mol Sci. 2022;23(3):1818.","journal-title":"Int J Mol Sci"},{"key":"2496_CR4","doi-asserted-by":"crossref","unstructured":"Letafati A, Sakhavarz T, Khosravinia MM, Ardekani OS, Sadeghifar S, Norouzi M et al. Exploring the correlation between progression of human papillomavirus infection towards carcinogenesis and nutrition. Microb Pathog. 2023:106302.","DOI":"10.1016\/j.micpath.2023.106302"},{"key":"2496_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","volume":"231","author":"N Egawa","year":"2017","unstructured":"Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017;231:119\u201327.","journal-title":"Virus Res"},{"issue":"1","key":"2496_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1473-3099(05)70323-6","volume":"6","author":"JM Partridge","year":"2006","unstructured":"Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis. 2006;6(1):21\u201331.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"2496_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","volume":"41","author":"HW Chesson","year":"2014","unstructured":"Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"2496_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5125\/jkaoms.2016.42.6.327","volume":"42","author":"SM Kim","year":"2016","unstructured":"Kim SM. Human papilloma virus in oral cancer. J Korean Association Oral Maxillofacial Surg. 2016;42(6):327.","journal-title":"J Korean Association Oral Maxillofacial Surg"},{"issue":"1","key":"2496_CR9","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1038\/s41598-024-57085-z","volume":"14","author":"A Abate","year":"2024","unstructured":"Abate A, Munshea A, Nibret E, Alemayehu DH, Alemu A, Abdissa A, et al. Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women. Sci Rep. 2024;14(1):7976.","journal-title":"Sci Rep"},{"issue":"12","key":"2496_CR10","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/ijerph19127213","volume":"19","author":"M Kole\u015bnik","year":"2022","unstructured":"Kole\u015bnik M, St\u0119pie\u0144 E, Polz-Dacewicz M. Prevalence of human papillomavirus (HPV) in the oral cavity of a healthy Population in South-Eastern Poland. Int J Environ Res Public Health. 2022;19(12):7213.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2496_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/LGT.0000000000000596","volume":"25","author":"L Serrano","year":"2021","unstructured":"Serrano L, L\u00f3pez AC, Gonz\u00e1lez SP, Palacios S, Dexeus D, Centeno-Mediavilla C, et al. Efficacy of a Coriolus versicolor\u2013based vaginal gel in women with human papillomavirus\u2013dependent cervical lesions: the PALOMA study. J Lower Genit Tract Dis. 2021;25(2):130.","journal-title":"J Lower Genit Tract Dis"},{"key":"2496_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-020-01360-1","volume":"22","author":"LA Wilson","year":"2021","unstructured":"Wilson LA, Quan AM, Bota AB, Mithani SS, Paradis M, Jardine C, et al. Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination. BMC Fam Pract. 2021;22:1\u201312.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"2496_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/infdis\/jiy507","volume":"219","author":"X Zhao","year":"2019","unstructured":"Zhao X, Zhao S, Hu S, Zhao K, Zhang Q, Zhang X, et al. Role of human papillomavirus DNA load in predicting the long-term risk of cervical cancer: a 15-year prospective cohort study in China. J Infect Dis. 2019;219(2):215\u201322.","journal-title":"J Infect Dis"},{"issue":"1","key":"2496_CR14","doi-asserted-by":"publisher","first-page":"03224","DOI":"10.1128\/mbio","volume":"12","author":"S Peng","year":"2021","unstructured":"Peng S, Ferrall L, Gaillard S, Wang C, Chi W-Y, Huang C-H, et al. Development of DNA vaccine targeting E6 and E7 proteins of human papillomavirus 16 (HPV16) and HPV18 for immunotherapy in combination with recombinant vaccinia boost and PD-1 antibody. MBio. 2021;12(1):03224\u201320. https:\/\/doi.org\/10.1128\/mbio.","journal-title":"MBio"},{"key":"2496_CR15","doi-asserted-by":"publisher","first-page":"1150238","DOI":"10.3389\/fimmu.2023.1150238","volume":"14","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, et al. Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective. Front Immunol. 2023;14:1150238.","journal-title":"Front Immunol"},{"issue":"2","key":"2496_CR16","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Global Health"},{"issue":"3","key":"2496_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"7","key":"2496_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/v15071440","volume":"15","author":"A-L Williamson","year":"2023","unstructured":"Williamson A-L. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15(7):1440.","journal-title":"Viruses"},{"issue":"5","key":"2496_CR19","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"27","key":"2496_CR20","doi-asserted-by":"publisher","first-page":"18786","DOI":"10.18632\/oncotarget.24666","volume":"9","author":"M Kaliff","year":"2018","unstructured":"Kaliff M, Sorbe B, Mordhorst LB, Helenius G, Karlsson MG, Lillsunde-Larsson G. Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy. Oncotarget. 2018;9(27):18786.","journal-title":"Oncotarget"},{"issue":"3","key":"2496_CR21","first-page":"637","volume":"52","author":"D Boda","year":"2018","unstructured":"Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, et al. Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues. Int J Oncol. 2018;52(3):637\u201355.","journal-title":"Int J Oncol"},{"issue":"5","key":"2496_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/CCO.0b013e32836242b4","volume":"25","author":"DC Beachler","year":"2013","unstructured":"Beachler DC, D\u2019Souza G. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol. 2013;25(5):503\u201310.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2496_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13027-022-00421-7","volume":"17","author":"I Rezaee Azhar","year":"2022","unstructured":"Rezaee Azhar I, Yaghoobi M, Mossalaeie MM, Kollaee Darabi A, Nejadeh AH, Jamshidi M, et al. Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran. Infect Agents Cancer. 2022;17(1):7.","journal-title":"Infect Agents Cancer"},{"key":"2496_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-019-0241-x","volume":"14","author":"M Davarmanesh","year":"2019","unstructured":"Davarmanesh M, Dezfulian M, Gharavi MJ, Younesi S, Saadati P, Amin MMT, et al. Human papilloma virus (HPV) genotypes concordance between Iranian couples referrals. Infect Agents Cancer. 2019;14:1\u20138.","journal-title":"Infect Agents Cancer"},{"key":"2496_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00296-6","volume":"15","author":"M Davarmanesh","year":"2020","unstructured":"Davarmanesh M, Jazayeri SM, Dezfulian M, Gharavi MJ. High risk genotype distribution of human papillomavirus (HPV) according to age groups in Iranian asymptomatic men. Infect Agents Cancer. 2020;15:1\u20135.","journal-title":"Infect Agents Cancer"},{"issue":"2","key":"2496_CR26","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1002\/ijc.26488","volume":"131","author":"N Khodakarami","year":"2012","unstructured":"Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, et al. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer. 2012;131(2):E156\u201361.","journal-title":"Int J Cancer"},{"issue":"3","key":"2496_CR27","first-page":"135","volume":"4","author":"A Moradi","year":"2011","unstructured":"Moradi A, Nosrat SB, Besharat S. Molecular epidemiology of high-risk types of human papillomaviruses (16, 18) in pap-smear, the North East of Iran. Iran J cancer Prev. 2011;4(3):135.","journal-title":"Iran J cancer Prev"},{"key":"2496_CR28","doi-asserted-by":"crossref","unstructured":"Salehi-Vaziri M, Sadeghi F, Hashemi FS, Haeri H, Bokharaei-Salim F, Monavari SH et al. Distribution of human papillomavirus genotypes in Iranian women according to the severity of the cervical lesion. Iran Red Crescent Med J. 2016;18(4).","DOI":"10.5812\/ircmj.24458"},{"key":"2496_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijid.2021.07.071","volume":"111","author":"F Bitarafan","year":"2021","unstructured":"Bitarafan F, Hekmat MR, Khodaeian M, Razmara E, Ashrafganjoei T, Gilani MM, et al. Prevalence and genotype distribution of human papillomavirus infection among 12 076 Iranian women. Int J Infect Dis. 2021;111:295\u2013302.","journal-title":"Int J Infect Dis"},{"issue":"1\u20132","key":"2496_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000477848","volume":"60","author":"E Taghizadeh","year":"2017","unstructured":"Taghizadeh E, Taheri F, Abdolkarimi H, Ghorbani Renani P, Gheibi Hayat SM. Distribution of human papillomavirus genotypes among women in Mashhad, Iran. Intervirology. 2017;60(1\u20132):38\u201342.","journal-title":"Intervirology"},{"issue":"3","key":"2496_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.30699\/IJP.2019.90356.1861","volume":"14","author":"MM Kesheh","year":"2019","unstructured":"Kesheh MM, Keyvani H. The prevalence of HPV genotypes in Iranian population: an update. Iran J Pathol. 2019;14(3):197.","journal-title":"Iran J Pathol"},{"issue":"4","key":"2496_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000485898","volume":"60","author":"R Hamkar","year":"2018","unstructured":"Hamkar R, Shoja Z, Ghavami N, Heydari N, Farahmand M, Jalilvand S. Type-specific human papillomavirus prevalence in Iranian women with normal cervical cytology: the impact of current HPV vaccines. Intervirology. 2018;60(4):125\u201330.","journal-title":"Intervirology"},{"issue":"4","key":"2496_CR33","first-page":"529","volume":"7","author":"SR Ghaffari","year":"2006","unstructured":"Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev. 2006;7(4):529\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2496_CR34","doi-asserted-by":"crossref","unstructured":"Javanmard D, Namaei MH, Haghighi F, Ziaee M, Behravan M, Mirzaei J et al. The frequency and typing of human Papilloma virus among women with normal and abnormal cytology in Southern Khorasan, Eastern Iran. Jundishapur J Microbiol. 2017;10(4).","DOI":"10.5812\/jjm.43213"},{"key":"2496_CR35","doi-asserted-by":"crossref","unstructured":"Jalilian S, Izadi B, Madani SH, Mohajeri P. The prevalence and genotype distribution of human papillomavirus types in the general female population in West of Iran. Jundishapur J Microbiol. 2017;10(3).","DOI":"10.5812\/jjm.40855"},{"key":"2496_CR36","doi-asserted-by":"publisher","first-page":"1225652","DOI":"10.3389\/fpubh.2023.1225652","volume":"11","author":"C Han","year":"2023","unstructured":"Han C, Huang W, Ye M, Zou R, Lan J, Chen J, et al. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China. Front Public Health. 2023;11:1225652.","journal-title":"Front Public Health"},{"issue":"7","key":"2496_CR37","doi-asserted-by":"publisher","first-page":"e0272205","DOI":"10.1371\/journal.pone.0272205","volume":"17","author":"RM Correa","year":"2022","unstructured":"Correa RM, Baena A, Valls J, Colucci MC, Mendoza L, Rol M, et al. Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America. PLoS ONE. 2022;17(7):e0272205.","journal-title":"PLoS ONE"},{"issue":"12","key":"2496_CR38","first-page":"3373","volume":"18","author":"S Ahmadi","year":"2017","unstructured":"Ahmadi S, Goudarzi H, Jalilvand A, Esmaeilzadeh A. Human papilloma virus genotype distribution in cervical lesions in Zanjan, Iran. Asian Pac J Cancer Prevention: APJCP. 2017;18(12):3373.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"4","key":"2496_CR39","first-page":"46","volume":"23","author":"K Hajibagheri","year":"2018","unstructured":"Hajibagheri K, Abaszade A, Afrasiabian S, Verdi F, Roshani D, Abdi F, et al. Frequency of human papilloma virus genotypes among woman with genitalia lesion, Sanandaj, Iran. Sci J Kurdistan Univ Med Sci. 2018;23(4):46\u201352.","journal-title":"Sci J Kurdistan Univ Med Sci"},{"issue":"1","key":"2496_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-024-02373-3","volume":"21","author":"M Haddadi","year":"2024","unstructured":"Haddadi M, Atefmehr L, Motlaghzadeh S, Hejami F, Elyasi FS, Zafarian N, et al. Prevailing of HPV-16 and 52 genotype in 2022\u20132023 in Sanandaj, Iran. Virol J. 2024;21(1):1\u20138.","journal-title":"Virol J"},{"issue":"5","key":"2496_CR41","first-page":"18","volume":"23","author":"S Moniri Javadhesari","year":"2020","unstructured":"Moniri Javadhesari S, Khakpour K, Pourseif S, Mozaffari H. Common genotypes of human papillomavirus in East Azerbaijan population using HPV Direct Flow CHIP Kit. Iran J Obstet Gynecol Infertility. 2020;23(5):18\u201325.","journal-title":"Iran J Obstet Gynecol Infertility"},{"issue":"17","key":"2496_CR42","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.3390\/diagnostics13172765","volume":"13","author":"R Parvez","year":"2023","unstructured":"Parvez R, Vijayachari P, Saha MK, Biswas L, Ramasamy J, Vins A, et al. Distribution of human papillomavirus genotypes among the women of South Andaman Island, India. Diagnostics. 2023;13(17):2765.","journal-title":"Diagnostics"},{"issue":"1","key":"2496_CR43","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1038\/s41598-017-13299-y","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Xu H, Xu W, Zeng W, Liu J, Wu Q, et al. Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015. Sci Rep. 2017;7(1):14813.","journal-title":"Sci Rep"},{"issue":"9","key":"2496_CR44","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","volume":"11","author":"L Bruni","year":"2023","unstructured":"Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Global Health. 2023;11(9):e1345\u201362.","journal-title":"Lancet Global Health"},{"issue":"1","key":"2496_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4274\/jtgga.galenos.2022.2022-6-6","volume":"24","author":"S Hakimi","year":"2023","unstructured":"Hakimi S, Lami F, Allahqoli L, Alkatout I. Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review. J Turkish German Gynecol Association. 2023;24(1):48.","journal-title":"J Turkish German Gynecol Association"},{"key":"2496_CR46","doi-asserted-by":"crossref","unstructured":"Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H et al. Towards elimination of cervical cancer\u2013human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health\u2013Western Pac. 2023;39.","DOI":"10.1016\/j.lanwpc.2023.100860"},{"issue":"3","key":"2496_CR47","first-page":"102","volume":"13","author":"N Hazar","year":"2021","unstructured":"Hazar N, Mousavi SA, Hosseini S. Recommendations on human papilloma virus vaccination to reduce the incidence of Cervical Cancer: yes or no in the current Situation. Iran J Blood Cancer. 2021;13(3):102\u20134.","journal-title":"Iran J Blood Cancer"},{"key":"2496_CR48","doi-asserted-by":"publisher","first-page":"101438","DOI":"10.1016\/j.pmedr.2021.101438","volume":"23","author":"N Sargazi","year":"2021","unstructured":"Sargazi N, Takian A, Yaseri M, Daroudi R, Motlagh AG, Nahvijou A, et al. Mothers\u2019 preferences and willingness-to-pay for human papillomavirus vaccines in Iran: a discrete choice experiment study. Prev Med Rep. 2021;23:101438.","journal-title":"Prev Med Rep"},{"issue":"1","key":"2496_CR49","first-page":"68","volume":"19","author":"F Mohammadpour","year":"2020","unstructured":"Mohammadpour F, Mansouri A, Hadjibabaie M. Utilization evaluation of human papilloma Virus Vaccine (GARDASIL\u00ae) in Iran; a cross-sectional study. Iran J Pharm Research: IJPR. 2020;19(1):68.","journal-title":"Iran J Pharm Research: IJPR"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02496-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:06:15Z","timestamp":1726808775000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02496-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2496"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02496-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval has been obtained (IR.TUMS.SPH.REC.1402.317), and written consent to participate has been received from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We utilize Large Language Models (LLMs), such as ChatGPT, exclusively for enhancing the quality of grammar while maintaining ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of an LLM"}}],"article-number":"227"}}